Retatrutide - My Experience
Shownotes
She lost 37% of her body weight. In nine months. On a drug that doesn't officially exist yet in the real world.
In this episode, Paddy & Belinda down with Mimi , an Australian nurse and stroke survivor who became one of a handful of people worldwide to trial Retatrutide, Eli Lilly's next-generation triple receptor GLP-1 agonist, as part of a landmark cardiovascular clinical trial.
Mimi pulls back the curtain on what it's really like to be inside a pharmaceutical trial, from being forced to dose-escalate to 12mg within months regardless of how her body was responding, to surviving a cold turkey stop after 20 months with zero tapering support.
She shares the unfiltered truth about what extreme appetite suppression actually feels like, how she rebuilt her nutrition from scratch when she couldn't keep liquids down, and the moment her DEXA scan revealed how much body fat she actually lost.
She also talks about the mental health reality nobody warned her about, the terrifying return of hunger after nearly two years of silence, why her blood pressure medication had to be stopped just four months in, and how she went from qualifying for a trial to now maintaining a nine stone weight on Wegovy for cardiovascular protection.
Plus, we get into the very real and dangerous black market surge of so-called 'Retatrutide' , and why if you're seeing it for sale online, it is not the real thing.
This is one of the most extraordinary first-hand accounts of Retatrutide you'll hear anywhere. Don't miss it.
Find Mimi Here: https://www.tiktok.com/@Mimi_in_Aus
Find Paddy Here: https://linktr.ee/paddyc
Fina Belinda here: https://www.instagram.com/glp1.insights
Tap here to send us a whatsapp message or if you can’t tap, simply send your message to: +353851343766
Disclaimer:
This podcast shares personal experience and general information only. It is not intended as medical advice. Always speak with a qualified healthcare professional about individual health decisions, including nutrition or prescription treatments. This episode is not endorsing, or suggesting any medical treatments - thats a decision for you and your Drs only.
Keywords: #Retatrutide #GLP1 #WeightLossMedication #Ozempic #ClinicalTrial #WeightLossJourney